Table 1.
Comorbid conditions and symptoms of hospitalized (n = 48) and non- hospitalized (n = 53) patients with COVID-19. All variables are reported as the number and percentage (%). The P-values were calculated using Fisher's exact test, with 2 × 2 contingency tables
| Status |
P-value | ||
|---|---|---|---|
| Hospitalizedn (%) | Non-hospitalizedn (%) | ||
| Comorbid conditions | |||
| Pregnancy | 0 (0) | 2 (4) | 0.3190 |
| Obesity | 6 (13) | 14 (26) | 0.0000 |
| Cancer | 0 (0) | 1 (2) | 1.0000 |
| Diabetes | 31 (65) | 11 (21) | 0.0000 |
| HTN | 32 (67) | 4 (8) | 0.0000 |
| HIV/immune deficiency | 2 (4) | 0 (0) | 0.2234 |
| Heart disease | 10 (21) | 3 (6) | 0.0353 |
| Asthma | 3 (6) | 3 (6) | 1.0000 |
| Chronic lung disease | 6 (13) | 0 (0) | 0.0097 |
| Chronic liver disease | 0 (0) | 2 (4) | 0.4962 |
| Chronic hematological disease | 3 (6) | 1 (2) | 0.3439 |
| Chronic renal disease | 25 (52) | 1 (2) | 0.0000 |
| Chronic neurological disease | 1 (2) | 0 (0) | 0.4752 |
| Organ or bone marrow recipient | 3 (6) | 0 (0) | 0.1038 |
| On ACEI/ARB | 2 (4) | 2 (4) | 0.6664 |
| On oral hypoglycemic agents/ insulin | 19 (40) | 3 (6) | 0.0001 |
| On active chemotherapy | 1 (2) | 0 (0) | 0.4752 |
| On long-term steroids | 4 (8) | 1 (2) | 0.1880 |
| On biologics | 1 (2) | 0 (0) | 0.4752 |
| Symptoms | |||
| Shortness of breath | 38 (79) | 9 (17) | 0.0000 |
| Fever | 30.(62.5%) | 41 (77.4) | 0.1286 |
| Cough | 26.00 (54.17) | 27 (50.9) | 0.8425 |
| Fatigue | 10.00 (20.83) | 30 (56.6) | 0.0003 |
| Diarrhea | 7.00 (14.58) | 18 (34) | 0.0368 |
| Nausea/vomiting | 6.00 (12.5) | 16 (30.2) | 0.0520 |
| Loss of appetite | 6.00 (12.5) | 4 (7.5) | 0.5117 |
| Muscle/joint pain | 5.00 (10.42) | 14 (26.4) | 0.0454 |
| Headache | 4.00 (8.33) | 11 (20.8) | 0.0977 |
| Sore throat | 3.00 (6.25) | 26 (49.1) | 0.0000 |
| Chills | 3.00 (6.25) | 3 (5.7) | 1.0000 |
| Loss of smell | 2.00 (4.17) | 25 (47.2) | 0.0000 |
| Neurological deficits or seizure | 2.00 (4.17) | 0 (0) | 0.2234 |
| Runny nose | 1.00 (2.8) | 23 (43.4) | 0.0000 |
| Rash | 0.00 (0) | 0 (0) | NA |
| Epistaxis | 0.00 | 0 | NA |
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; HTN, hypertension; NA, not applicable.